Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Personal Best

Protecting patients is what the pharma industry is all about, but it must also ensure that laboratory and healthcare personnel are safe from risks including the toxic cytostatic agents used in chemotherapy treatments

Ian Samson, DuPont (December 2013)

Keywords: Cytostatic drugs, Personal protection equipment, Particle emission, Barrier efficiency tests

    View full article    |    Back to Analytical Laboratory Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |